Rationale Pulmonary hypertension (PH) represents a serious health complication accompanied with hypoxic conditions, elevated levels of asymmetric dimethylarginine (ADMA), and overall dysfunction of pulmonary vascular endothelium. Since the prevention strategies for treatment of PH remain largely unknown, our study aimed to explore the effect of nitro-oleic acid (OA-NO 2 ), an exemplary nitro-fatty acid (NO 2 -FA), in human pulmonary artery endothelial cells (HPAEC) under the influence of hypoxia or ADMA. Methods HPAEC were treated with OA-NO 2 in the absence or presence of hypoxia and ADMA. The production of nitric oxide (NO) and interleukin-6 (IL-6) was monitored using the Griess method and ELISA, respectively. The expression or activation of different proteins (signal transducer and activator of transcription 3, STAT3; hypoxia inducible factor 1α, HIF-1α; endothelial nitric oxide synthase, eNOS; intercellular adhesion molecule-1, ICAM-1) was assessed by the Western blot technique. Results We discovered that OA-NO 2 prevents development of endothelial dysfunction induced by either hypoxia or ADMA. OA-NO 2 preserves normal cellular functions in HPAEC by increasing NO production and eNOS expression. Additionally, OA-NO 2 inhibits IL-6 production as well as ICAM-1 expression, elevated by hypoxia and ADMA. Importantly, the effect of OA-NO 2 is accompanied by prevention of STAT3 activation and HIF-1α stabilization. Conclusion In summary, OA-NO 2 eliminates the manifestation of hypoxia-and ADMA-mediated endothelial dysfunction in HPAEC via the STAT3/HIF-1α cascade. Importantly, our study is bringing a new perspective on molecular mechanisms of NO 2 -FAs action in pulmonary endothelial dysfunction, which represents a causal link in progression of PH.
Introduction
Pulmonary hypertension (PH) is a progressive vasculopathy with high prevalence in certain at-risk groups (e.g. patients with chronic obstructive pulmonary disease, cystic fibrosis, systemic sclerosis, sickle cell disease, and HIV) [1] [2] [3] [4] [5] . Nowadays, it is well accepted that PH is linked with endothelial dysfunction, caused by imbalance in vasoactive mediators (e.g. nitric oxide, NO and prostaglandin I 2 ), increased production and expression of inflammatory molecules (such as interleukin-6, IL-6 and intracellular adhesion molecule 1, ICAMElectronic supplementary material The online version of this article (doi:10.1007/s10557-016-6700-3) contains supplementary material, which is available to authorized users. 1) as well as activation of various pro-inflammatory and proproliferative signaling pathways (including signal transducer and activator of transcription 3, STAT3 and hypoxia-inducible factor 1-α, HIF-1α) (reviewed in [2] ).
Importantly, it has also been discovered that PH is accompanied by increased systemic levels of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of endothelial nitric oxide synthase (eNOS), which serves as a predictor of mortality in patients with PH [4] [5] [6] [7] . Recently, ADMA levels have been found to be increased in human pulmonary artery endothelial cells (HPAEC) exposed to hypoxia, showing the possibility that ADMA might serve as an intermediary molecule in hypoxic effects [8] . Our group has also shown that it represents a critical regulator of human pulmonary vascular functions. ADMA decreased the bioavailability of NO via inhibition of activation and expression of endothelial nitric oxide synthase (eNOS), responsible for NO synthesis in HPAEC [9] . Additionally, ADMA caused the up-regulation of pro-inflammatory mediator production (IL-6; ICAM-1; platelet-derived growth factor, PDGF; and Regulated on Activation Normal T cell Expressed and Secreted, RANTES) via STAT3/HIF-1α signaling cascade, resulting in development of PH phenotype in HPAEC [9] . Based on the above-mentioned findings, we suggest that ADMA and STAT3/HIF-1α cascade are potential therapeutic targets for future clinical interventions in PH.
Evidence implies that nitro-fatty acids (NO 2 -FAs), known for their pleiotropic anti-inflammatory, anti-proliferative, and cardioprotective actions [10] [11] [12] [13] are suitable candidates for prevention of hypoxia-and ADMA-enhanced PH phenotype in endothelial cells (ECs). Electrophilic NO 2 -FAs induce reversible post-translational modification of susceptible nucleophilic amino acids of proteins via Michael addition and they are expected to influence numerous signaling pathways (including STATs; nuclear factor-κB, NF-κB; mitogen activated protein kinases, MAPKs; Kelch ECH associating protein 1/ nuclear factor erythroid 2-related factor 2, Keap1/Nrf2 system, and peroxisome proliferator-activated receptor-γ, PPAR-γ) [10, 11, 14, 15] . NO 2 -FAs inhibit cell proliferation; reduce infarct size, atherosclerotic plaque development, macrophage activation in murine models of cardiac ischemia and reperfusion, atherosclerosis as well as systemic hypertension [10, 11, 13] . Importantly, our recent study indicated that NO 2 -FAs are able to prevent hypoxia-induced PH in a mouse model [16] . To help to elucidate molecular mechanisms of this phenomenon, an in vitro model of hypoxia-induced PH was employed in our study.
Therefore, we decided to be the first to examine the effect of nitro-oleic acid (OA-NO 2 ), an exemplary NO 2 -FA, in our recently published hypoxia-and ADMA-induced model of endothelial dysfunction [9] , which represents a highly suitable environment for testing the ability of different compounds to interfere with the development of the PH phenotype in human primary cells. Our experiments were focused on determination of specific molecules and proteins (NO, eNOS, IL-6, and ICAM-1), detection of adhesive properties and migration activity of HPAEC as well as on activation of specific signaling cascades (STAT3/HIF1a) involved in the development of PH [2, [17] [18] [19] .
Material and Methods
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich (St. Louis, MO). The OA-NO 2 (mixture of isomers (E)-9-and 10-nitro-octadec-9-enoic acid; for structure see Fig. 1 ) was provided by the Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh PA, USA. The OA-NO 2 was diluted up to 100 mM solution in concentrated methanol and stored at −80°C. For experimental application, 10 mM solution of OA-NO 2 in methanol was prepared and diluted in Dulbecco's Modified Eagle's Medium (DMEM; PAN-Biotech, Aidenbach, Germany) to obtain 100 μM OA-NO 2 . The fresh solution of OA-NO 2 was used immediately for treatment of cells [20] . In our experiments we used final concentration 1.0 μM. All stocks were prepared in sterile lowbinding tubes.
Cell Cultures
HPAEC (Lonza, Switzerland) were cultivated in complete EGM™-2 medium (Lonza). Confluent cells at passage 2-5 were used for the experiments. Experiments were performed in basic medium supplemented with 2 % of fetal bovine serum (FBS).
Detection of Cell Viability
Cell viability was measured based on total cellular mass of adherent cells using the detergent-compatible protein assay reagent (Bio-Rad, USA) with bovine serum albumin as a standard [9] . Cell viability was not significantly decreased in any of the tested groups (data not shown). 
Determination of NO Production
The production of nitrites (the end product of NO metabolism in cultivation medium) was measured by the Griess assay [9] . Equal volume of supernatants (150 μl) and Griess reagent were mixed and incubated for 30 min at room temperature. The absorbance (540 nm) was measured using SPECTRA Sunrise microplate reader (Tecan, Mannedorf, Switzerland).
Detection of Protein Expression Using a Western Blot Technique
The expression of proteins was detected in cell lysates as described previously [9] . Briefly, an equal amount of proteins (25 μg) was loaded to 10 % SDS-polyacrylamide gel and transferred to immobilon polyvinylidene difluoride membrane (Immobilon-P, Millipore, Billerica, MA, USA). Membranes with transferred proteins were incubated with primary antibodies against phospho-STAT3 (pSTAT3, Tyr705), STAT3, eNOS (Cell Signaling Technology, USA) or against ICAM-1 and HIF-1α (Santa Cruz Biotechnology, USA). Membranes incubated with secondary antibody were visualized into CP-B X-ray films (Agfa, Brno, Czech Republic). Relative levels of proteins were analyzed and quantified using the ImageJ™ program (National Institutes of Health, USA). Individual band density value is expressed in optical density. An equal protein concentration was verified by blotting of β-actin (Santa Cruz Biotechnology). The data in graphs represent the ratio between the individual values for OD of bands determined for phosphorylated and total form of protein and total form against β-actin.
Quantitative Determination of the Cytokine Levels
Concentration of human IL-6 was measured by commercially available human ELISA DuoSet kit (R&D Systems, USA). Cell supernatants were processed in agreement with supplier's instructions [20] .
Characterization of Migration Activity
The migration of HPAEC was detected using the scratchwound assay, which is simple and commonly used to measure basic cell migration parameters. HAPEC were grown to confluence and a thin cross was introduced by scratching a pipette tip. The migration of cells into the cross-space was monitored after 24 h and was analyzed and quantified using the ImageJ™ program (9) .
Characterization of Adhesive Properties
For the adhesion experiments, HPAEC were cultured in 96-well tissue culture plates (Genetix, USA) until confluent.
HPAEC were left either unstimulated or stimulated for 24 h with or without ADMA (100 μM) and/or OA-NO 2 (1.0 μM). Isolated human neutrophils were loaded with fluorescent dyecalcein-AM (1 μM) for 20 min at 37°C in the dark and washed. The adhesion of neutrophils to HPAEC was quantified under static conditions. Before the adhesion assay was performed, HPAEC were washed and basic medium supplemented with 2 % FBS was applied to cells. Labeled neutrophils were applied at a density of 5 × 10 3 cells/well to the HPAEC surface and allowed to adhere for 1 h at 37°C with gentle rocking. Non-adherent cells were removed by washing two times with HBSS. The relative fluorescence intensity of adherent neutrophils was analyzed by an Infinite M200 microplate spectrofluorimeter with excitation and emission wavelengths of 480 and 530 nm (21) . Results are displayed as % of positive control (tumor necrosis factor-α, 50 ng/ml).
Data Analysis
Data were statistically analyzed using the one-way analysis of variance (ANOVA), which was followed by Bonferonni's multiple comparison test (GraphPad Prism 5.01). All data are reported as means ± SEM. A p value of less than 0.05 was considered significant. The statistical comparison is represented as follows: in all the graphs, letter a represents the significant difference between a group of data in the first bar and a group of data in the other bars, b represents the significant difference between the second and the other bars, c represents the significant difference between the third and the other bars and d represents the significant difference between the fourth and the other bars.
Results
The effect of OA-NO 2 was tested in the well-established model of HPAEC exposed to hypoxia [8, 9, 16] or ADMA [9] . The control group represented HPAEC cultivated under normoxic conditions (21 % of O 2 , 5 % of CO 2 ), which were not exposed to ADMA or OA-NO 2 . Another group of cells was treated with OA-NO 2 (1.0 μM) under normoxic conditions. Further, the cells were exposed to hypoxic conditions (5 % of O 2 , 90 % of N 2 , 5 % of CO 2 ) or ADMA (100 μM). The last group of cells was exposed to combination of hypoxia or ADMA together with OA-NO 2 (1.0 μM). The treatment conditions were selected based on our previously published results [16, 20] .
OA-NO 2 Prevents Hypoxia-Induced Endothelial Dysfunction and Activation of Intracellular Signaling Pathways in HPAEC
As we expected, hypoxia (5 % of O 2 ) induced a significant decrease in NO production as well as eNOS expression determined in cells cultivated for 48 h (Figs. 2a, b) . Moreover, hypoxia caused an increased production of IL-6 (Fig. 2c) and expression of ICAM-1 (Fig. 2d) . Further, hypoxia-induced pro-inflammatory phenotype in ECs was effectively prevented by OA-NO 2 (1.0 μM) (Fig. 2a, b, c and d) .
In the following experiments we confirmed our recently published observation [9] that hypoxia-induced PH phenotype in HPAEC is connected with increased phosphorylation of STAT3 (60 min) (Fig. 2e, f) and consequent stabilization of HIF-1α (24 h) (Fig. 2g) . We discovered that OA-NO 2 (1.0 μM) was able to effectively prevent these processes, indicating the potential usage of OA-NO 2 in prevention of hypoxia-induced PH manifestation in HPAEC (Fig. 2e, f and g ).
OA-NO 2 Prevents ADMA-Induced Endothelial Dysfunction in HPAEC
Similar experiments were performed with ADMA. As we had expected, ADMA (100 μM) was also able to trigger the PH phenotype in HPAEC treated for 48 h (Fig. 3) [9] . Importantly, OA-NO 2 (1.0 μM) completely prevented ADMA-induced endothelial dysfunction, characterized by a significant decrease in NO production (Fig. 3a) and eNOS expression (Fig. 3b) as well as an enhanced production of IL-6 ( Fig. 3c) and an increased expression of ICAM-1 (Fig. 3d) . Moreover, we found that OA-NO 2 effectively downregulates the ADMAinduced migration of HPAEC to the wound space (Fig. 3e , Suppl. 1) as well as the ability of human neutrophils to adhere to HPAEC (Fig. 3f, Suppl. 2) .
Next, we examined the potential involvement of OA-NO 2 in ADMA-mediated activation of STAT3/HIF-1α signaling pathway, shown to be involved in development of PH phenotype in human endothelial and smooth muscle cells [9] . Expression and activation of STAT3 was determined in HPAEC exposed to ADMA (100 μM) and/or OA-NO 2 (1.0 μM) for 15, 30, and 60 min (Fig. 4a, b and c) . Additionally, stabilization of HIF-1α was assessed at 60 min and 24 h after cell incubation (Fig. 4d, e) . We discovered that OA-NO 2 completely abolished the ADMA-upregulated phosphorylation of STAT3 (Fig. 4a, b and c) . This phenomenon was accompanied with OA-NO 2 -mediated prevention of ADMA-induced HIF-1α stabilization in both time points selected (Fig. 4d, e) .
Discussion
This study was conducted to uncover the role of NO 2 -FAs in prevention of PH phenotype induced in HPAEC. The effect of OA-NO 2 was tested in our previously established model of hypoxia-and ADMA-mediated endothelial dysfunction [9] . The current study brought unique results which showed that OA-NO 2 is able to critically regulate pulmonary EC functions. This conclusion is based on several important findings. (1) We showed for the first time that OA-NO 2 (1.0 μM) prevents hypoxia-and ADMA-induced downregulation of NO production as well as eNOS expression. It is well known that hypoxia and ADMA reduce NO bioavailability by affecting enzyme activity as well as protein expression of eNOS [9, 20, 21] , which is in accordance with results presented in this study. Interestingly, it has been previously described that at higher concentrations, NO 2 -FAs (3.0-5.0 μM) might be a direct source of NO, mediating endothelium-dependent vasorelaxation [22] [23] [24] [25] , however in vivo NO 2 -FAs do not acutely affect blood pressure or heart rate [11, 13] . In our study, OA-NO 2 had no effect on NO production or eNOS expression in intact HPAEC, suggesting that 1.0 μM of OA-NO 2 does not represent the significant source of NO release. Vessel relaxation studies are in apparent contradiction to the observation that NO 2 -FA-derived release of NO in aqueous media (following Nef-like acid-base chemistry) is inhibited by intercalation in micelles and liposomes, leading to NO release of little or no biological significance [22, 26] . Additionally, NO 2 -FAs were shown to mediate elevation of NO levels rather via activation of different signaling molecules (e.g. protein kinase B and extracellular signal regulated kinases 1/2) in human umbilical vein endothelial cells (HUVEC) and coronary aortic and bovine aortic endothelial cells (BAEC) [12, 23] . Based on these facts and presented data we suppose that the OA-NO 2 -mediated upregulation of hypoxia-and ADMA-decreased NO production is not a consequence of direct release of NO from OA-NO 2 , but is dependent on activation/inhibition of signaling pathways described in more details below.
(2) In the following experiments we discovered that OA-NO 2 inhibits hypoxia-and ADMA-induced production of IL-6 and expression of ICAM-1, which confirmed the antiinflammatory potential of NO 2 -FAs in the development of PH phenotype in HPAEC. As mentioned above, proinflammatory mediators such as cytokines, chemokines, and adhesion molecules play an important role in the development of endothelial dysfunction and pathogenesis of PH induced by different kinds of stimuli (e.g. hypoxia and ADMA) (reviewed in [2] ). In our study, the exposure of hypoxia-and ADMAtreated HPAEC to OA-NO 2 was associated with prevention of IL-6 production and ICAM-1 expression in these cells. ADMA-and OA-NO 2 -induced changes in ICAM-1 expression corresponded with the ability of neutrophils to adhere to HPAEC. These results confirmed previous observations where the inhibitory effect of NO 2 -FAs (nitro-linoleic acid, L-NO 2 and OA-NO 2 ) on IL-6 and ICAM-1 was also described by several authors in different in vitro and in vivo models [11, 14, 27, [28] [29] [30] . These findings were supported by functional assays demonstrating OA-NO 2 ability to reduce ADMAinduced migration activity of HPAEC.
(3) Importantly, we are the first to report that OA-NO 2 blocks the phosphorylation of STAT3 within tens of minutes after HPAEC exposition to hypoxia or ADMA. STAT3 is a cytoplasmic transcription factor, activated in response to different kinds of stimuli (e.g. hypoxia, ADMA, and IL-6) (reviewed in [18] ), which regulate diverse cellular processes including growth, survival, and inflammation [17, 18] . Recently, several downstream STAT3 targets, associated with PH manifestation, have also been identified [2, 17, 18] . STAT3 was shown to be required for increased HIF-1α expression in response to hypoxia, which consequently leads to expression of genes responsible for regulation of critical cellular functions (reviewed in [31] ). Likewise, ADMA was also shown to induce stabilization of HIF-1α in a STAT3-dependent manner [9] . These results show that inhibition of STAT3 phosphorylation by OA-NO 2 (1.0 μM) is associated with prevention of HIF-1α stabilization in HPAEC treated with either hypoxia or ADMA. In contrast to our results, Rudincki et al. [32] demonstrated that NO 2 -FAs (L-NO 2 and OA-NO 2 , final concentration 10.0 μM) are able to upregulate protein expression of HIF-1α and HIF-1α targeted genes, leading to increased migration and development of proangiogenic phenotype in HUVEC. Interestingly, Wu et al. [30] , also showed that OA-NO 2 (2.5 μM) increases HIF-1α protein expression via activation of heme oxygenase-1 pathway in BAEC. The authors suggest that this signaling pathway might play an essential role in compensating or protecting vascular endothelial function against vascular injury [30] . We hypothesize that these inconsistent results are a consequence of distinct concentration of NO 2 -FAs (1.0 μM vs. 2.5-10.0 μM) used in experiments as well as with different cellular models investigated (HPAEC vs. HUVEC and BAEC). Nevertheless, in our model OA-NO 2 -dependent inhibition of HIF-1α stabilization was accompanied with prevention of endothelial dysfunction in HPAEC, described in previous sections. Importantly, our results supply and strongly support our previous study, where OA-NO 2 was shown to prevent development of hypoxia-induced PH [16] . In that study, OA-NO 2 significantly attenuated hypoxia-induced right ventricular hypertrophy and fibrosis in mice as well as activation of macrophages and smooth muscle cells in vitro [16] . STAT3 has also been implicated in the inhibition of eNOS expression and NO production by increased binding of STAT3 on the eNOS promoter [33] . These facts are consistent with data presented in our study, where hypoxia-and ADMA-induced activation of STAT3 correlates with reduced bioavailability of NO and expression of eNOS. A similar mechanism has been described for STAT3-dependent regulation of cytokine production (e.g. IL-6 and IL-10), ICAM-1 expression, and migration induced in vascular ECs [17] .
In conclusion, we suggest that OA-NO 2 -mediated inhibition of STAT3 is the primary mechanism of how this compound supports NO production and eNOS expression and blocks IL-6 production and ICAM-1 expression in HPAEC influenced by hypoxia or ADMA. However, we cannot exclude the involvement of other signaling pathways in later phases of endothelial dysfunction (e.g. NF-κB, MAPKs, Keap1/Nrf2 system, and PPAR-γ). Importantly, our results imply that NO 2 -FAs might significantly alter the development of endothelial dysfunction and inflammatory processes in the lungs.
Clinical Relevance
Development of pulmonary hypertension (PH) significantly increases the morbidity and mortality in patients with chronic lung diseases. Only few clinical therapies exist for the treatment of PH and prevention strategies remain largely unknown. Our study is bringing a new perspective on the molecular mechanism of nitro-fatty acid (NO 2 -FAs) action in hypoxia-and asymmetric dimethylarginine-induced pulmonary endothelial dysfunction, representing a causal link in the progression of PH. Nitro-oleic acid blocks upregulation of signal transducer and activator of transcription 3/hypoxia-inducible factor 1-alpha signaling cascade, which results in prevention of the PH phenotype in human pulmonary endothelial cells. We suggest that NO 2 -FAs represent potential pharmaceuticals that could be used for future clinical interventions in PH.
